Sisram Medical Ltd
SRAMF
$0.535
$0.5350.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | -54.66% | 0.00% | 29.42% | 0.00% |
| Total Depreciation and Amortization | 0.00% | -1.69% | 0.00% | 2.31% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | -225.27% | 0.00% | 202.30% | 0.00% |
| Change in Net Operating Assets | -- | -- | 0.00% | -- | -- |
| Cash from Operations | 0.00% | -116.79% | 0.00% | 635.22% | 0.00% |
| Capital Expenditure | 0.00% | -46.35% | 0.00% | -1.54% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00% | -182.54% | 0.00% |
| Cash Acquisitions | -- | -- | 0.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | 101.61% | 0.00% | -219.89% | 0.00% |
| Cash from Investing | 0.00% | 88.47% | 0.00% | -271.48% | 0.00% |
| Total Debt Issued | 0.00% | 294.63% | 0.00% | 67.11% | 0.00% |
| Total Debt Repaid | 0.00% | -149.27% | 0.00% | -69.80% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | 0.00% | -- | -- |
| Other Financing Activities | 0.00% | -530.97% | 0.00% | 231.38% | 0.00% |
| Cash from Financing | 0.00% | 59.24% | 0.00% | -382.61% | 0.00% |
| Foreign Exchange rate Adjustments | 0.00% | 5,438.46% | 0.00% | 104.62% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | -110,966.67% | 0.00% | -100.09% | 0.00% |